GGrantIndex
Sort

4,870 grants matching glp 1

GLP-1R signaling in allergic inflammation

$395,000
Ray Stokes Peebles · Vanderbilt University Medical Center · R01 · FY2017 · AI

Islet Cell and ST2 Axis Dysregulation in Post-Transplant Diabetes Mellitus

$395,000
Brian G Engelhardt · Vanderbilt University Medical Center · R01 · FY2020 · HL

Islet Cell and ST2 Axis Dysregulation in Post-Transplant Diabetes Mellitus

$395,000
Brian G Engelhardt · Vanderbilt University Medical Center · R01 · FY2021 · HL

Prevention of arthritis-induced bone erosion by inhibiting osteoclast differentiation by the haloanilide, N-Methyl Dichloropropionaniline

$394,939
John B Barnett · Exesalibero, Inc. · R42 · FY2021 · AR

Glucocorticoid Receptor Coregulators and Insulin Sensitivity

$394,684
Jen-Chywan Wang · University Of California Berkeley · R01 · FY2022 · DK

Drug Development of GLP-1 receptor agonists

$394,655
Josephine Egan · National Institute On Aging · ZIA · FY2012 · AG

Novel metabolic actions of GIP

$392,832
Jonathan E Campbell · Duke University · R01 · FY2020 · DK

Role of Glucokinase in GLP-1 Regulation of Energy and Glucose Homeostasis

$392,500
Darleen A Sandoval · University Of Cincinnati · R01 · FY2010 · DK

Pharmacologic Enhancement of Viral Oncolysis

$392,403
E. Antonio Chiocca · Massachusetts General Hospital · P01 · FY2008 · CA

CELL PROCESSING AND GENE THERAPY

$392,248
Elizabeth Marion Jaffee · Johns Hopkins University · P30 · FY2013 · CA

Link of beta cell proliferation and type 2 diabetes to epigenetic regulation

$392,200
Xianxin Hua · University Of Pennsylvania · R01 · FY2010 · DK

Role of the Renin-Angiotensin System in Glucose Homeostasis

$392,118
Sakeneh Zraika · Seattle Inst For Biomedical/Clinical Res · R01 · FY2025 · DK

*Enhancement of tumor targeting and chemotherapeutic ac*

$391,837
Christopher P Leamon · Endocyte, Inc. · R44 · FY2006 · CA

Sustained release depot pre-exposure prophylaxis in breast feeding populations

$391,705
Thomas J. Smith · Auritec Pharmaceuticals, Inc. · R44 · FY2006 · HD

The role of intestinal SCD1 in regulating metabolic health

$391,632
Harini Sampath · Rutgers, The State Univ Of N.J. · R01 · FY2022 · DK

The role of intestinal SCD1 in regulating metabolic health

$391,632
Harini Sampath · Rutgers, The State Univ Of N.J. · R01 · FY2021 · DK

The role of intestinal SCD1 in regulating metabolic health

$391,632
Harini Sampath · Rutgers, The State Univ Of N.J. · R01 · FY2025 · DK

The role of intestinal SCD1 in regulating metabolic health

$391,632
Harini Sampath · Rutgers, The State Univ Of N.J. · R01 · FY2023 · DK

Manufacturing of Trojan Horse-TNFR Decoy Receptor Fusion Protein

$391,592
Ruben J. Boado · Armagen Technologies, Inc. · R44 · FY2013 · AG

Antibody-based prertargeted alpha particle therapy for ovarian cancer

$391,553
Michael King Schultz · Viewpoint Molecular Targeting, Inc. · R42 · FY2024 · CA

Understanding the role of bile as a mechanism for improved glucose homeostasis fo

$391,269
April Dawn Strader · Southern Illinois University Carbondale · RC1 · FY2009 · DK

EGF and TGF-β signaling synergy in β-cell proliferation

$391,250
George K. Gittes · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · DK

Role of the Renin-Angiotensin System in Glucose Homeostasis

$390,455
Sakeneh Zraika · Seattle Inst For Biomedical/Clinical Res · R01 · FY2023 · DK

Improving beta-cell function in Mexican American women with prediabetes

$390,187
Willa A. Hsueh · Ohio State University · R01 · FY2014 · MD

Beta-cell Proliferation

$390,151
Mehboob A Hussain · Johns Hopkins University · R01 · FY2012 · DK